NRC earnings date and last-quarter result: P/E 52.94. Updated 2026-07-23.
NRC Health (NRC) Research Hub
NRC Health (NRC) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-10-26, shares last closed at 22.45 USD (+2.37%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 52.94, market cap 0.48B. This hub links to the full technical, earnings and options research available for NRC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Information Services) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 22.45 USD (+2.37%) |
| 52-week range | 17.61 USD – 23.68 USD |
| Trend regime | Range |
| 14-day RSI | 70.8 (Overbought) |
| Trailing P/E | 52.94 |
| Market cap | 0.48B |
| Dividend yield | 2.78% |
Available research for NRC
Covered Call on NRC: how it works, illustrative setup around the real 22.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NRC: how it works, illustrative setup around the real 22.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NRC: how it works, illustrative setup around the real 22.45 USD price, max profit/loss, breakeven and when to use it. Educational.
NRC technical analysis: range, last 22.45 USD, RSI 70.8, 52w range 17.61 USD–23.68 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NRC in?
NRC Health (NRC) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, US.
Is NRC in an uptrend or downtrend?
As of 2026-10-26, NRC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NRC's trailing P/E ratio?
NRC's trailing P/E is 52.94, with a market cap of 0.48B. See the earnings research page for full valuation detail.